Go Pro
TSE:SVA

Sernova (SVA) Stock Price, News & Analysis

Sernova logo
C$0.10 -0.01 (-5.00%)
As of 09/23/2026 04:24 PM Eastern

About Sernova Stock (TSE:SVA)

Advanced

Key Stats

Today's Range
C$0.10
C$0.11
50-Day Range
C$0.10
C$0.14
52-Week Range
C$0.10
C$0.20
Volume
455,403 shs
Average Volume
142,777 shs
Market Capitalization
C$35.88 million
P/E Ratio
N/A
Dividend Yield
7.86%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.

Receive SVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SVA Stock News Headlines

FY2026 Earnings Forecast for Sernova Issued By HC Wainwright
How to get a stake in Anthropic — before the IPO
Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its valuation has doubled since the announcement, with some estimates putting the company's worth near 3 trillion dollars by IPO day. Google, Amazon, Nvidia and Microsoft have all taken stakes, while Goldman Sachs, Morgan Stanley and JPMorgan are competing for private shares. Anthropic's annualized revenue reportedly grew 80 times in the first quarter alone. See how investors are positioning ahead of this closely watched IPO.tc pixel
SERNOVA BIOTHERAPEUTICS INC
Sernova Biotherapeutics Inc.
See More Headlines

SVA Stock Analysis - Frequently Asked Questions

Sernova's stock was trading at C$0.13 on January 1st, 2026. Since then, SVA shares have decreased by 26.9% and is now trading at C$0.10.

Sernova Corp. (TSE:SVA) released its quarterly earnings data on Thursday, September, 10th. The company reported ($0.01) EPS for the quarter.

Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sernova investors own include ARC Resources (ARX), Meta Platforms (META), Newron Pharmaceuticals (NWPHF), Sernova Biotherapeutics (SEOVF), AMC Entertainment (AMC), Advanced Micro Devices (AMD) and CloudMD Software & Services (DOC).

Company Calendar

Last Earnings
9/10/2026
Today
9/23/2026

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
TSE:SVA
CIK
N/A
Fax
N/A
Employees
1,959
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$35.70 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
57.10%
Return on Assets
-119.26%

Debt

Debt-to-Equity Ratio
-21.98
Current Ratio
0.03
Quick Ratio
18.11

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.02 per share
Price / Cash Flow
6.15
Book Value
C($0.03) per share
Price / Book
-3.05

Miscellaneous

Outstanding Shares
377,643,000
Free Float
N/A
Market Cap
C$35.88 million
Optionable
Not Optionable
Beta
-0.43
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (TSE:SVA) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners